218 related articles for article (PubMed ID: 9074847)
1. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne.
Brogden RN; Goa KE
Drugs; 1997 Mar; 53(3):511-9. PubMed ID: 9074847
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
[TBL] [Abstract][Full Text] [Related]
3. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
Clucas A; Verschoore M; Sorba V; Poncet M; Baker M; Czernielewski J
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S116-8. PubMed ID: 9204089
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on adapalene in acne vulgaris.
Waugh J; Noble S; Scott LJ
Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
[TBL] [Abstract][Full Text] [Related]
5. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients.
Zhu XJ; Tu P; Zhen J; Duan YQ
Cutis; 2001 Oct; 68(4 Suppl):55-9. PubMed ID: 11845949
[TBL] [Abstract][Full Text] [Related]
6. A review of adapalene in the treatment of acne vulgaris.
Irby CE; Yentzer BA; Feldman SR
J Adolesc Health; 2008 Nov; 43(5):421-4. PubMed ID: 18848668
[TBL] [Abstract][Full Text] [Related]
7. Adapalene, a new chemical entity with retinoid activity.
Bernard BA
Skin Pharmacol; 1993; 6 Suppl 1():61-9. PubMed ID: 8142113
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
[TBL] [Abstract][Full Text] [Related]
9. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Ioannides D; Rigopoulos D; Katsambas A
Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
[TBL] [Abstract][Full Text] [Related]
10. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
Caron D; Sorba V; Kerrouche N; Clucas A
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S110-2. PubMed ID: 9204087
[TBL] [Abstract][Full Text] [Related]
11. Topical tretinoin or adapalene in acne vulgaris: an overview.
Jain S
J Dermatolog Treat; 2004 Jul; 15(4):200-7. PubMed ID: 15764031
[TBL] [Abstract][Full Text] [Related]
12. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
Keating GM
Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
[TBL] [Abstract][Full Text] [Related]
13. Adapalene: a review of its use in the treatment of acne vulgaris.
Waugh J; Noble S; Scott LJ
Drugs; 2004; 64(13):1465-78. PubMed ID: 15212561
[TBL] [Abstract][Full Text] [Related]
14. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Cunliffe WJ; Poncet M; Loesche C; Verschoore M
Br J Dermatol; 1998 Oct; 139 Suppl 52():48-56. PubMed ID: 9990421
[TBL] [Abstract][Full Text] [Related]
16. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne.
Czernielewski J; Michel S; Bouclier M; Baker M; Hensby JC
J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():5-12. PubMed ID: 11843234
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
Lucky A; Jorizzo JL; Rodriguez D; Jones TM; Stewart DM; Tschen EH; Kanof NB; Miller BH; Wilson DC; Loven KH
Cutis; 2001 Oct; 68(4 Suppl):34-40. PubMed ID: 11845946
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.
Cunliffe WJ; Caputo R; Dreno B; Förström L; Heenen M; Orfanos CE; Privat Y; Robledo Aguilar A; Meynadier J; Alirezai M; Jablonska S; Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart JM; Swinyer L; Whitmore C; Czernielewski J; Verschoore M
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S126-34. PubMed ID: 9204091
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of adapalene.
Michel S; Jomard A; Démarchez M
Br J Dermatol; 1998 Oct; 139 Suppl 52():3-7. PubMed ID: 9990413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]